In 2017, over 40 pharmaceutical ventures went public in China

On average, there were 4 IPO per month, and nearly 90 % of the companies had VC/PE support. The original investment period of 8-10 years was reduced to about 3-5 years. Total funds raised reached over 200 billion yuan. China Bio news release, November 30,...

China’s youngest academician, Tao XU (徐涛)

A biomedical engineer by education, Tao XU is presently Director of the Innovation Center of Instruments and Technologies for Life Sciences at CAS Beijing Institute of Life Sciences. His focus is on membrane and vesicle transport. Born in May 1970, he was a postdoc...

CFDA proposes law to simplify certification of drugs

According to a CFDA law amendment brought to congress vote, certification of drugs in China might be simplified in the future: 1. permission for manufacture and GMP certificate will be combined in one certificate, and 2. permission for storage (GSP = good storage...

Cyanobacterial sucrose synthesis is closely linked to glycogen pool

Cyanobacteria such as Synechococcus sp. PCC 7942 overproduce sucrose to achieve osmotolerance in saline solution. The teams around Xuefeng LU and Quan LUO at CAS Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT), in collaboration with Martin Hagemann...